AtriCure (ATRC) Earnings Analysis

AtriCure (ATRC) next reports earnings on 2026-07-23, consensus EPS -0.00167 USD. Last quarter (2026-02-17) it beat with EPS 0.06 USD vs -0.04003 USD est (+249.9%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -342.74.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ATRC next report earnings?

Next earnings date2026-07-23
Consensus EPS estimate-0.00167 USD
Revenue estimate0.15B

ATRC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-170.06 USD-0.04003 USD+249.9%Beat
2025-10-29-0.01 USD-0.11 USD+90.9%Beat
2025-02-12-0.08 USD-0.23 USD+65.2%Beat

Beat rate: 3/3 (100%) over reported quarters with consensus data.

ATRC valuation and analyst view

Trailing P/E-342.74
Trailing EPS-0.09503 USD
Price / book3.30
Dividend yield0.00%
Market cap1.71B
Analyst consensusBuy (18 buy / 1 hold / 0 sell)
Avg price target53.5 USD

Related research pages

Frequently asked questions

When is AtriCure (ATRC)'s next earnings date?

AtriCure is next scheduled to report on 2026-07-23, with a consensus EPS estimate of -0.00167 USD and revenue estimate of 0.15B.

Did ATRC beat earnings last quarter?

In its 2026-02-17 report, ATRC posted EPS of 0.06 USD versus a -0.04003 USD estimate — a beat of 249.9%.

What is ATRC's earnings track record?

Over the last 3 reported quarters with consensus data, ATRC beat estimates 3 times (100%).

What is ATRC's current P/E ratio and EPS?

ATRC trades at a trailing P/E of -342.74 on trailing EPS of -0.09502627549964827 USD.

What do analysts rate ATRC?

Analyst consensus is "Buy" across 19 ratings (0 strong buy, 18 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 53.5 USD.